ArcheMedX predicts and improves team and clinician performance, optimizing clinical trial delivery and accelerating clinical adoption for 21 of the top 25 pharmaceutical firms, emerging biotechs, and global CROs. The Company’s behavioral science-based learning and predictive analytics platform, Ready, improves clinical trial team performance by identifying risks sooner and tailoring more effective on-demand training to individual needs. Ready is used by 250,000+ clinical professionals in more than 90 countries. Trial sponsors and CROs utilize Ready to reduce the time (and burden) required to select and activate sites, improve the effectiveness of study training, and mitigate trial risk across: • protocol and site feasibility • naïve site readiness • study training and site initiation • Rater training • CRA training and oversight • workforce development • patient education (coming soon) More than 96% of site personnel report they are better prepared to screen and enroll patients sooner after using Ready and 100% of customers that initially deploy the Ready platform renew their license and expand use. Learn how Ready reveals study risks sooner and delivers more tailored, role specific training at www.archemedx.com/ready